Current Issue: November 2026
Feature
Recent Developments and Novel Therapeutics in Alcohol-Associated Liver Disease
Abstract: The landscape of alcohol-associated liver disease (ALD) has changed dramatically in the past two decades. Gut dysbiosis has emerged as a critical driver of ALD […]
Advances in Endoscopy
Ampullary Adenoma: How Far Can Endoscopic Papillectomy Go?
G&H What is the current role of endoscopic papillectomy in the management of ampullary adenomas? FB First, a note on terminology. In the duodenum, the ampulla […]
Advances in Hepatology
Antibiotic Prophylaxis in Patients With Cirrhosis
G&H How strong is the evidence supporting prophylactic antibiotic use for upper gastrointestinal bleeding in patients with cirrhosis? AD-R Based on multiple studies that have been […]
MASH in Focus
Novel Risk Scores in Metabolic Dysfunction-Associated Steatohepatitis
G&H Why has there been a push to develop new risk scores in metabolic dysfunction-associated steatohepatitis when there are already commonly used scores like the Fibrosis-4 […]
Letter From the Editor
Letter From the Editor: Delving Into the Pathophysiology and Management of Alcohol-Associated Liver Disease
What is new in the field of alcohol-associated liver disease? Our feature article in this month’s issue of Gastroenterology & Hepatology explores this question. Dr Avesh […]
Advances in IBS
New Ways to Evaluate for Evacuation Disorders
G&H How do you feel the London classification and Rome V criteria have influenced the evaluation of patients with evacuation disorders and specifically dyssynergia? ES The […]
Supplements:
Highlights in MASH From the American College of Gastroenterology 2026 Annual Scientific Meeting
A Review of Selected Presentations From the ACG 2026 Annual Scientific Meeting October 9-14, 2026 • Nashville, Tennessee Machine Learning Models of Noninvasive Tests to Predict […]